The role of Sur8 in the specific regulation of transformation and migration of CRC cells, without affecting their normal growth, further highlights the importance of Sur8 as a potential target for cancer therapy, especially cancers with Ras mutations. This evidence concerns the gene SHOC2 and colorectal carcinoma.